The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
about
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisFluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.Lymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis.Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer.Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer.Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancerThe role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays.mTOR signaling in cancer cell motility and tumor metastasis.Role of mTOR signaling in tumor cell motility, invasion and metastasisLymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.Bevacizumab in the treatment of NSCLC: patient selection and perspectives.Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.[Expression and prognostic value of VEGF-C and lymphangeogenesis in lung adenocarcinoma and squamous cell carcinoma].
P2860
Q26797490-348C26D1-ED75-4C4C-9AFF-16BF00D38C24Q30419853-D5DF3731-77F6-4F59-BA7E-1C08B92E1E93Q33479161-540B156F-9660-4FD7-982B-F6EC799BD6B0Q33819978-836B5051-6E0B-4D8B-96E7-92FB423E863DQ34795562-14C2C906-41AB-4886-9620-D375F51AFD0FQ35584074-78700543-3466-441B-BC51-C5106AE364B8Q35784523-7351EF0E-AB3C-4D1C-AB8C-700FD76F113CQ36589860-BBAB5FAE-E7ED-4A75-9B3F-9E6E7FD9CBD0Q37175922-298421CD-C4AA-49BD-98AE-B7449D873CFFQ37763231-6D408C67-B37E-41CA-8E00-386A40E41D1FQ37824477-E4CC322B-DFBA-489B-A6A7-B652FEF4EAB5Q39263241-8AA2F80B-764D-44A1-BF2E-39BBEABEAC7EQ39799414-B5C5533E-FA89-49B3-87B5-EF3054FB1A68Q40147274-84586359-EC2F-43F2-9CCD-9997B8C4C248Q47168527-6B5B7F99-F2A9-4BAC-B0C0-822A3483ABACQ54977595-85D3B65B-8BAD-40DB-99CF-EF3B6A1513A9Q55429219-91E148D3-8AE1-4A9E-B1C9-C3A3D0D8E086
P2860
The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@ast
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@en
type
label
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@ast
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@en
prefLabel
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@ast
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
The balance of VEGF-C and VEGF ...... in non-small cell lung cancer.
@en
P2093
Sakiyama S
Takizawa H
P2860
P2888
P356
10.1038/SJ.BJC.6603209
P407
P577
2006-06-06T00:00:00Z